坎地沙坦酯对肾移植术后高血压受者肾功能的影响
被引量：3
摘要
高血压是肾移植术后的常见并发症，其发病率达90％，肾移植术后高血压（FFH）与心血管疾病的发生率、病死率以及肾功能的恶化密切相关。也是导致移植肾慢性排斥的一个重要的非免疫性因素，对移植肾长期存活可产生重要影响，以往钙通道阻断药（CCB）是被大多数移植中心用于治疗PTH的首选药物，近年来，由于肾血管紧张素系统抑制药（包括血管紧张素转化酶抑制剂和血管紧张素Ⅱ受体拮抗剂）不仅具有良好的降压作用。而且能显著降低心、脑血管事件的发生和对肾脏的保护作用等优点，
出处
《中国药物与临床》
CAS
2010年第2期209-210,共2页
Chinese Remedies & Clinics
参考文献5
-
1贾瑞鹏,尹广.免疫抑制治疗对肾移植患者血压的影响[J].肾脏病与透析肾移植杂志,2003,12(3):290-293. 被引量：9
-
2Paul LC,Benediktsson H. Post-transplant hypertension and chronic renal failure.Kidney Int, 1995,48 : 34-37.
-
3Easthope SE,Jarvis B. Candesartan cilexetil an update of its use in essential hypertension.Drugs, 2002,62 : 1253-1287.
-
4Brenner BM.Cooper ME,de Zeeuw D,et al.Effects of losartan on renal and cardiovascular outcomes in patients witll type 2 diabetes and nephropathy.New Engl Med, 2001,345 : 861-869.
-
5李宁,武小桐,贾志缃,郝晓军,张小红,陈好雨,马永文.坎地沙坦酯治疗肾移植术后早期高血压的临床观察[J].中国药物与临床,2007,7(1):69-71. 被引量：1
二级参考文献43
-
1胡蓉,罗开良,王翼平.国产坎地沙坦酯治疗轻中度原发性高血压的随机双盲临床试验[J].重庆医科大学学报,2006,31(1):91-94. 被引量：10
-
2Veenstra DL, Best JH, Hornberger J, et al. Incidence and long term cost of steroid related side effects after renal transplantation.Am J Kidney Dis,1999,33:829.
-
3Pirsch JD, Miller J, Deierhor MH, et al.A comparison of tacrolimus(FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. Transplantation, 1997,63 : 977.
-
4Sander M,Lyson T,Thomas GD, et al . Sympathetic neural mechanisms of cyclosporine induced hypertension. Am J Hypertens1996, 9(S) : 121.
-
5Haas M, Mayer G. Cyclosporin A-associated hypertension-pathomechanisms and clinical consequences. Nephrol Dial Transplant, 1997,12:395.
-
6Taler SJ,Textor SC, Canzanello VJ, et al. Cyclosporine induced hypertension: Incidence, pathogenesis and management. Drug Saf, 1999,20:437.
-
7Shin GT, Khanna A, Ding R, et al. In vivo expression of transforming growth factor-betal in humans: stimulation by cyclosporine. Transplantation . 1998.65:313.
-
8Boots JMM, Christiaans M HL, van Duijnhoven EM, et al. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study . Transplantation , 2002,74: 1 703.
-
9Vincenti F, Jensik SC, Filo RS, et al.A Long-term comparison of tacrolimus(FK506) and cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years. Transplantation, 2002, 73:775.
-
10Margreiter R. Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in renal transplantation: A randomized multicentre study, lancet, 2002,359: 741.
共引文献8
-
1贾瑞鹏,季曙明.肾移植术后高血压治疗的新进展[J].医学研究生学报,2005,18(3):258-261. 被引量：3
-
2梁秋梅,莫新少.肾移植术后并发高血压的护理现状[J].医学文选,2005,24(4):648-649.
-
3贾瑞鹏,季曙明.雷帕霉素防治慢性移植肾肾病的新进展[J].医学研究生学报,2005,18(10):934-938. 被引量：3
-
4李宁,武小桐,贾志缃,郝晓军,张小红,陈好雨,马永文.坎地沙坦酯治疗肾移植术后早期高血压的临床观察[J].中国药物与临床,2007,7(1):69-71. 被引量：1
-
5王茜,潘迪,张春媛,高建.对肾移植术后高血压患者实施连续护理干预的探讨[J].华西医学,2014,29(7):1355-1357.
-
6翟颖,蒋媛,朱立勤,田雪飞.肝移植术后高血压患者的药学监护[J].中国医院用药评价与分析,2014,14(8):749-751.
-
7张春媛,高建,姜伟,刘彦斌,成伟丽.个体化健康教育对肾移植术后高血压患者的效果分析[J].中国疗养医学,2014,23(11):1028-1029. 被引量：1
-
8贾瑞鹏,季曙明.移植肾纤维化的分子病理研究[J].肾脏病与透析肾移植杂志,2003,12(5):485-489. 被引量：2
同被引文献25
-
1李松杨,赵学智,刘亚玲.尿毒症患者偶测血压与动态血压的对比研究[J].中国血液净化,2004,3(7):377-379. 被引量：6
-
2刘必成.延缓慢性肾脏病进展的现代策略[J].继续医学教育,2006,20(5):57-67. 被引量：7
-
3National kidney Foundation-K/DOQI. Clinical practice guidelines for chronic kidney disease, evaluation, classification and stratification [J]. AMJ Kidney Dis, 2002, 39 (suppl1) :s1-s266.
-
4Beliizzi V, Di Iorio BR, De Nicola L, et al. Very low protein diet supplemented with Ketoanalogs improves blood pressure contral in chronic kidney disease [J]. Kidney Int, 2007, 71 (3): 245-251.
-
5lkizler TA.CKD classification: time to move beyond KDOQI [J]. J Am Soc Nephrol, 2009, 20 (5) : 929-930.
-
6Cupisti A, Aparicio M, Barsotti G. Potential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients [J]. Renal Fail, 2007, 29 (5) : 529-534.
-
7Appel L J, Brands MW, Daniels SR, et al. Dietaryapproaches to prevent and treat hypertension: a scientific statement from the American Heart Association[J]. Hypertension, 2006, 47 (2): 296-308.
-
8Vassalotti JA, Uribarri J, Chen SC, et al. Trends in mineral metabolism: kidney early evaluation program (KEEP) and the national health and nutrition examination survey (NHANES) 1999-2004[J]. Am J Kidney Dis, 2008, 51 (4 Suppl 2): S56-S68.
-
9Levin A, Bakris GL, Molitch M, et al. Prevalence of abnormal serum vitamin D, PTH, calciumand phosphorus in patients with chronic kidney disease: results of study to evaluate early kidney disease [J]. Kidney Int, 2007, 71 (1): 31-38.
-
10马培龙,姜国红,王锐艳,孙薇,张洪波.低蛋白饮食联合复方α-酮酸治疗在慢性肾脏病中的应用[J].中国血液净化,2008,7(9):494-497. 被引量：18
二级引证文献6
-
1付水鸽.肾康注射液联合复方α-酮酸治疗慢性肾衰的效果观察[J].中医临床研究,2015,7(31):84-85. 被引量：2
-
2李松杨,顾波,马骏,董蓓晔,赵颖丹,王汉清.复方α酮酸对CKD3~5期非透析慢性肾脏病患者的降压作用探讨[J].世界临床药物,2016,37(2):115-119. 被引量：6
-
3李红微,刘胜阳,刘云霞,张菊.复方α-酮酸联合羟苯磺酸钙治疗慢性肾功能不全的效果观察[J].中国当代医药,2016,23(7):74-76. 被引量：4
-
4李松杨,顾波,陈松,马骏,武立群,董蓓晔,赵颖丹,王汉清,易扬,宣怡.偶测血压正常的慢性肾脏病患者的动态血压特点[J].上海医学,2016,39(9):526-531. 被引量：3
-
5李昌艳.复方α酮酸治疗慢性肾脏病的疗效观察[J].重庆医学,2017,46(A01):338-339. 被引量：4
-
6唐立明,邱楚雄,覃娜,陈梅芳,刘绮,毛辉,龙世松,董芬芳.坤草芪莲汤治疗消渴病并尿微量蛋白的临床研究[J].现代中西医结合杂志,2018,27(35):3884-3887. 被引量：7
-
1李宁,武小桐,贾志缃,郝晓军,张小红,陈好雨,马永文.坎地沙坦酯治疗肾移植术后早期高血压的临床观察[J].中国药物与临床,2007,7(1):69-71. 被引量：1
-
2祝捷.中西医结合诊治糖尿病肾病（续）[J].中华医学信息导报,2011,26(22):22-22.
-
3张红梅.肾炎康复片与坎地沙坦酯治疗糖尿病肾病临床对比研究[J].中国实用医药,2013,8(22):136-137. 被引量：5
-
4李东彦.坎地沙坦酯治疗糖尿病肾病69例疗效观察[J].中国现代药物应用,2010,4(1):152-153.
-
5梁立强.不同剂量坎地沙坦酯治疗糖尿病肾病蛋白尿疗效观察[J].医学信息,2011,24(17):5747-5747. 被引量：1
-
6黄殿红,李廷振.坎地沙坦酯治疗早期糖尿病肾病32例[J].蚌埠医学院学报,2014,39(11):1553-1555. 被引量：4
-
7马登扬,陈挺,林连祥,张宝金.前列腺增生合并高血压患者术后血压变化分析[J].浙江临床医学,2007,9(4):470-470.
-
8刘齐贵,赵霞,邝丽新,戚恩荣,熊德顺,杨顺秋,王传达,杨树才.肾移植术后高血压的常规药物治疗[J].海南医学,2000,11(5):37-37.
-
9张杰秀,华立新,钱立新.肾移植术后高血压[J].国外医学（泌尿系统分册）,2004,24(3):372-375. 被引量：4
-
10刘红.肾移植术后高血压及处理原则[J].肾脏病与透析肾移植杂志,1994,3(6):530-534.
